![Ann Tsukamoto](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ann Tsukamoto
Plus aucun poste en cours
Historique de carrière de Ann Tsukamoto
Anciens postes connus de Ann Tsukamoto
Sociétés | Poste | Début | Fin |
---|---|---|---|
StemCells, Inc.
![]() StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Directeur Technique/Scientifique/R&D | 01/11/1997 | - |
Corporate Officer/Principal | 01/11/1997 | - |
Formation de Ann Tsukamoto
University of California, Los Angeles | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 3 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 1 |
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
StemCells, Inc.
![]() StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Health Technology |
- Bourse
- Insiders
- Ann Tsukamoto
- Expérience